Carlson Capital’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-909,721
Closed -$23.5M 256
2019
Q1
$23.5M Sell
909,721
-529,634
-37% -$14.7M 0.42% 73
2018
Q4
$35.2M Buy
1,439,355
+176,975
+14% +$4.8M 0.55% 51
2018
Q3
$36.4M Sell
1,262,380
-351,420
-22% -$9.99M 0.45% 51
2018
Q2
$42M Buy
1,613,800
+987,447
+158% +$25.5M 0.59% 35
2018
Q1
$18.2M Buy
626,353
+376,353
+151% +$11M 0.27% 98
2017
Q4
$6.57M Buy
+250,000
New +$7.14M 0.11% 192

Other funds holding BAK

Carlson Capital's BAK Position: Q2 2019 in Review

Carlson Capital sold out of Braskem (BAK) in Q2 2019, closing a stake of 909,721 shares — an estimated $23.5M sold.

Carlson Capital first reported a position in BAK in Q4 2017 and held it in 6 quarters. The position peaked at $42M in Q2 2018. 17 funds tracked by Wall St. Rank hold BAK as of Q2 2019.

  • Carlson Capital reported no remaining Braskem position as of Q2 2019 after selling out during the quarter.
  • Carlson Capital sold 909,721 Braskem shares in Q2 2019, an estimated $23.5M.
  • Carlson Capital first reported a position in Braskem in Q4 2017 and held it in 6 quarters.
  • Carlson Capital's Braskem position peaked at $42M in Q2 2018.
  • 17 funds tracked by Wall St. Rank held Braskem as of Q2 2019.

Based on Carlson Capital's 13F filing for Q2 2019, filed 12 Aug 2019.